Team:MIT/Team
From 2012.igem.org
(Difference between revisions)
Line 200: | Line 200: | ||
<div class="bio" id="kgbio"> | <div class="bio" id="kgbio"> | ||
<h1>Keren Greenbaum</h1> | <h1>Keren Greenbaum</h1> | ||
- | <img src="http://2012.igem.org/wiki/images/6/60/KerenGreenbaum.jpg" style="max-width: | + | <img src="http://2012.igem.org/wiki/images/6/60/KerenGreenbaum.jpg" style="max-width:250px; margin-right:10px;"/> |
is a rising junior at MIT studying Biological Engineering. She is specifically interested in using biological engineering for medical purposes such as cell and tissue regeneration. After MIT she is deciding between pursuing medicine or furthering her studies in bioengineering. She is excited to be participating in iGEM because it exposes her to all aspects of research from the formation of the goal to applicable papers to working in the lab. Outside of iGEM, she enjoys dancing ballet, is the Shabbat & Holidays VP for MIT Hillel and is on the MIT Sport Taekwondo Team. | is a rising junior at MIT studying Biological Engineering. She is specifically interested in using biological engineering for medical purposes such as cell and tissue regeneration. After MIT she is deciding between pursuing medicine or furthering her studies in bioengineering. She is excited to be participating in iGEM because it exposes her to all aspects of research from the formation of the goal to applicable papers to working in the lab. Outside of iGEM, she enjoys dancing ballet, is the Shabbat & Holidays VP for MIT Hillel and is on the MIT Sport Taekwondo Team. | ||
<div class="clear"></div> | <div class="clear"></div> | ||
Line 208: | Line 208: | ||
<div class="bio" id="gabio"> | <div class="bio" id="gabio"> | ||
<h1>Giulio Alighieri</h1> | <h1>Giulio Alighieri</h1> | ||
- | <img src="http://2012.igem.org/wiki/images/5/5b/GiulioAlighieri.jpg" style="max-width: | + | <img src="http://2012.igem.org/wiki/images/5/5b/GiulioAlighieri.jpg" style="max-width:250px; margin-right:10px;"/> |
is a first year PhD student at MIT Chemical Engineering Department. Giulio joined the MIT iGEM 2012 to enter the amazing world of synthetic biology. In particular he is extremely excited by the idea of using genetic circuits to let cells perform tasks that can have tremendous impact in curing human diseases, moreover he strongly desires to do research in synthetic biology for his PhD thesis. Giulio earned a Joined Triple Master Degree in Nanotechnology at Turin Polytechnic (Italy), EPFL(Switzerland) and Grenoble Institute of Technology(France) where he studied molecular biology. In addition he earned a Bachelor’s Degree in EECS at University of Naples FedericoII. His previous research experiences have been at the Max Planck Institute for Quantum Optics(Germany), MIT (for his master thesis) and IBM Almaden Research Center(California). In his free time Giulio loves to run, bike and play soccer. | is a first year PhD student at MIT Chemical Engineering Department. Giulio joined the MIT iGEM 2012 to enter the amazing world of synthetic biology. In particular he is extremely excited by the idea of using genetic circuits to let cells perform tasks that can have tremendous impact in curing human diseases, moreover he strongly desires to do research in synthetic biology for his PhD thesis. Giulio earned a Joined Triple Master Degree in Nanotechnology at Turin Polytechnic (Italy), EPFL(Switzerland) and Grenoble Institute of Technology(France) where he studied molecular biology. In addition he earned a Bachelor’s Degree in EECS at University of Naples FedericoII. His previous research experiences have been at the Max Planck Institute for Quantum Optics(Germany), MIT (for his master thesis) and IBM Almaden Research Center(California). In his free time Giulio loves to run, bike and play soccer. | ||
<div class="clear"></div> | <div class="clear"></div> | ||
Line 216: | Line 216: | ||
<div class="bio" id="dibio"> | <div class="bio" id="dibio"> | ||
<h1>Divya Israni</h1> | <h1>Divya Israni</h1> | ||
- | <img src="http://2012.igem.org/wiki/images/d/d1/DivyaIsrani.jpg" style="max-width: | + | <img src="http://2012.igem.org/wiki/images/d/d1/DivyaIsrani.jpg" style="max-width:250px; margin-right:10px;"/> |
is a rising senior at UC Berkeley, majoring in Bioengineering, with a focus on Cell and Tissue Engineering and Synthetic Biology. She is participating in the MIT iGEM team through the EBICS REU program. Divya's research interests are situated in understanding molecular mechanisms behind which cells function and the manner in which they can be manipulated through engineering to yield novel results, particularly for therapeutic purposes. After graduation, she plans to obtain her MS and/or PhD in Bioengineering. As a longer-term career objective, she aspires to pursue a position in the biotech or pharmaceutical industries to design novel bio-medical therapies. Divya's previous research experience includes metabolic engineering research using <i>E. coli</i> for bio-fuels synthesis at the Joint BioEnergy Institute under the direction of Dr. Jay Keasling, as well as identifying oxidative and nitrosative stress-resistant mechanisms of <i>E. histolytica</i> at the Stanford Department of Internal Medicine under the direction of Dr. Upinder Singh. In her free time, Divya enjoys swimming and dancing. She also actively volunteers at her local Berkeley/Oakland YWCA, mentoring young girls in science and technology, as well as planning and organizing community events such as Shadow Day. | is a rising senior at UC Berkeley, majoring in Bioengineering, with a focus on Cell and Tissue Engineering and Synthetic Biology. She is participating in the MIT iGEM team through the EBICS REU program. Divya's research interests are situated in understanding molecular mechanisms behind which cells function and the manner in which they can be manipulated through engineering to yield novel results, particularly for therapeutic purposes. After graduation, she plans to obtain her MS and/or PhD in Bioengineering. As a longer-term career objective, she aspires to pursue a position in the biotech or pharmaceutical industries to design novel bio-medical therapies. Divya's previous research experience includes metabolic engineering research using <i>E. coli</i> for bio-fuels synthesis at the Joint BioEnergy Institute under the direction of Dr. Jay Keasling, as well as identifying oxidative and nitrosative stress-resistant mechanisms of <i>E. histolytica</i> at the Stanford Department of Internal Medicine under the direction of Dr. Upinder Singh. In her free time, Divya enjoys swimming and dancing. She also actively volunteers at her local Berkeley/Oakland YWCA, mentoring young girls in science and technology, as well as planning and organizing community events such as Shadow Day. | ||
<div class="clear"></div> | <div class="clear"></div> | ||
Line 224: | Line 224: | ||
<div class="bio" id="lxbio"> | <div class="bio" id="lxbio"> | ||
<h1>Lealia Xiong </h1> | <h1>Lealia Xiong </h1> | ||
- | <img src="http://2012.igem.org/wiki/images/4/42/LealiaXiong.jpg" style="max-width: | + | <img src="http://2012.igem.org/wiki/images/4/42/LealiaXiong.jpg" style="max-width:250px; margin-right:10px;"/> |
is a rising sophomore studying physics at MIT, with an interest in biological and medical research. By participating in iGEM, she hopes to be able to explore the burgeoning field of synthetic biology by participating in a student-driven, focused project, and to gain knowledge regarding the applications of synthetic biology's techniques to human disease. Her previous laboratory experience includes studying the impact of environmental effects on cancer metastasis using the eyeful line of <i>Drosophila melanogaster</i> as a model. In addition to iGEM, she develops stunts and performs for MIT Lion Dance, serves on the logistics committee for MIT Techfair, and teaches for the Terrascope freshman learning community. | is a rising sophomore studying physics at MIT, with an interest in biological and medical research. By participating in iGEM, she hopes to be able to explore the burgeoning field of synthetic biology by participating in a student-driven, focused project, and to gain knowledge regarding the applications of synthetic biology's techniques to human disease. Her previous laboratory experience includes studying the impact of environmental effects on cancer metastasis using the eyeful line of <i>Drosophila melanogaster</i> as a model. In addition to iGEM, she develops stunts and performs for MIT Lion Dance, serves on the logistics committee for MIT Techfair, and teaches for the Terrascope freshman learning community. | ||
<div class="clear"></div> | <div class="clear"></div> | ||
Line 231: | Line 231: | ||
<div class="bio" id="rwbio"> | <div class="bio" id="rwbio"> | ||
<h1>Ron Weiss</h1> | <h1>Ron Weiss</h1> | ||
- | <img src="http://2011.igem.org/wiki/images/7/7b/Weiss.jpg" style="max-width: | + | <img src="http://2011.igem.org/wiki/images/7/7b/Weiss.jpg" style="max-width:250px;"/> |
joined the BE and EECS faculties as dual associate professor (with tenure) starting in July 2009, having moved from Princeton University where he held comparable rank in their department of electrical engineering and with a joint appointment in their department of molecular biology. His degrees are double BA in Computer Science and Economics from Brandeis University (1992), followed by SM and PhD in EECS at MIT (1994, 2001). Professor Weiss is a prominent and widely respected figure in the emerging field known as ‘synthetic biology’, with emphasis on designing molecular circuits governing cell behavior using quantitative systems modeling approaches. He is expected to help lead MIT’s efforts in both synthetic biology and systems biology, and indeed to guide their integration. | joined the BE and EECS faculties as dual associate professor (with tenure) starting in July 2009, having moved from Princeton University where he held comparable rank in their department of electrical engineering and with a joint appointment in their department of molecular biology. His degrees are double BA in Computer Science and Economics from Brandeis University (1992), followed by SM and PhD in EECS at MIT (1994, 2001). Professor Weiss is a prominent and widely respected figure in the emerging field known as ‘synthetic biology’, with emphasis on designing molecular circuits governing cell behavior using quantitative systems modeling approaches. He is expected to help lead MIT’s efforts in both synthetic biology and systems biology, and indeed to guide their integration. | ||
<div class="clear"></div> | <div class="clear"></div> | ||
Line 238: | Line 238: | ||
<div class="bio" id="jbbio"> | <div class="bio" id="jbbio"> | ||
<h1>Jonathan Babb</h1> | <h1>Jonathan Babb</h1> | ||
- | <img src="http://2011.igem.org/wiki/images/thumb/e/ea/Jbabb.jpg/571px-Jbabb.jpg" style="max-width: | + | <img src="http://2011.igem.org/wiki/images/thumb/e/ea/Jbabb.jpg/571px-Jbabb.jpg" style="max-width:250px;"/> |
is currently performing research to extend the life of silicon technology as well as to create the next generation of carbon-based computing platforms in the emergent fields of synthetic biology and BioCAD. Formerly, Jonathan was a lecturer at Princeton University and founder and CEO of a logic emulation startup. Dr. Babb earned a BS in electrical engineering from the Georgia Institute of Technology and an SM and PhD in electrical engineering and computer science from MIT. He is a member of the IEEE. | is currently performing research to extend the life of silicon technology as well as to create the next generation of carbon-based computing platforms in the emergent fields of synthetic biology and BioCAD. Formerly, Jonathan was a lecturer at Princeton University and founder and CEO of a logic emulation startup. Dr. Babb earned a BS in electrical engineering from the Georgia Institute of Technology and an SM and PhD in electrical engineering and computer science from MIT. He is a member of the IEEE. | ||
<div class="clear"></div> | <div class="clear"></div> | ||
Line 245: | Line 245: | ||
<div class="bio" id="dmbio"> | <div class="bio" id="dmbio"> | ||
<h1>Deepak Mishra</h1> | <h1>Deepak Mishra</h1> | ||
- | <img src="http://2011.igem.org/wiki/images/thumb/f/fc/Deepak.jpg/527px-Deepak.jpg" style="max-width: | + | <img src="http://2011.igem.org/wiki/images/thumb/f/fc/Deepak.jpg/527px-Deepak.jpg" style="max-width:250px;"/> |
is a NSF Graduate Fellow in MIT Biological Engineering and a student in Ron Weiss' Synthetic Biology Group. He is interested in synthetic protein phosphorylation networks and the emergence of multicellularity from single celed organisms. Deepak is a returning instructor and been instrumental in our success thus far. | is a NSF Graduate Fellow in MIT Biological Engineering and a student in Ron Weiss' Synthetic Biology Group. He is interested in synthetic protein phosphorylation networks and the emergence of multicellularity from single celed organisms. Deepak is a returning instructor and been instrumental in our success thus far. | ||
<div class="clear"></div> | <div class="clear"></div> | ||
Line 253: | Line 253: | ||
<div class="bio" id="pcbio"> | <div class="bio" id="pcbio"> | ||
<h1>Peter Andrew Carr </h1> | <h1>Peter Andrew Carr </h1> | ||
- | <img src="http://web.mit.edu/lms/www/images/people/Peter%20Carr,%20USA%20%28Custom%29.JPG" style="max-width: | + | <img src="http://web.mit.edu/lms/www/images/people/Peter%20Carr,%20USA%20%28Custom%29.JPG" style="max-width:250px;"/> |
leads the GeneFab research team at the Center for Bits and Atoms at the Massachusetts Institute of Technology. The goal of this work is to expand the limits of genetic engineering, from single genes to the engineering of complete genomes. He holds a Bachelors degree in Biochemistry from Harvard College and a Ph.D. in Biochemistry and Molecular Biophysics from Columbia University. Prior to his current position he was a post- doctoral research fellow in the lab of Peter S. Kim at the Whitehead Institute for Biomedical Research. | leads the GeneFab research team at the Center for Bits and Atoms at the Massachusetts Institute of Technology. The goal of this work is to expand the limits of genetic engineering, from single genes to the engineering of complete genomes. He holds a Bachelors degree in Biochemistry from Harvard College and a Ph.D. in Biochemistry and Molecular Biophysics from Columbia University. Prior to his current position he was a post- doctoral research fellow in the lab of Peter S. Kim at the Whitehead Institute for Biomedical Research. | ||
<div class="clear"></div> | <div class="clear"></div> | ||
Line 260: | Line 260: | ||
<div class="bio" id="lqbio"> | <div class="bio" id="lqbio"> | ||
<h1>Lulu Qian</h1> | <h1>Lulu Qian</h1> | ||
- | <img src="http://www.astrobio.net/images/galleryimages_images/Gallery_Image_7831.jpg" style="max-width: | + | <img src="http://www.astrobio.net/images/galleryimages_images/Gallery_Image_7831.jpg" style="max-width:250px;"/> |
is a Visiting Fellow in the Molecular System Lab in the Wyss Institute at Harvard University. She was a Senior Postdoctoral Scholar in Bioengineering at the California Institute of Technology from January 2011 to February 2012. Lulu is interested in engineering molecular systems with intelligent behaviors – at the basic level, such as recognizing molecular events from the environment, processing information, making decisions and taking actions. Her paper “Scaling up digital circuit computation with DNA strand displacement cascades” prompted the strand displacement idea for the MIT iGEM team, and she has been an invaluable resource to us. | is a Visiting Fellow in the Molecular System Lab in the Wyss Institute at Harvard University. She was a Senior Postdoctoral Scholar in Bioengineering at the California Institute of Technology from January 2011 to February 2012. Lulu is interested in engineering molecular systems with intelligent behaviors – at the basic level, such as recognizing molecular events from the environment, processing information, making decisions and taking actions. Her paper “Scaling up digital circuit computation with DNA strand displacement cascades” prompted the strand displacement idea for the MIT iGEM team, and she has been an invaluable resource to us. | ||
<div class="clear"></div> | <div class="clear"></div> | ||
Line 268: | Line 268: | ||
<div class="bio" id="nsbio"> | <div class="bio" id="nsbio"> | ||
<h1>Nevin M. Summers</h1> | <h1>Nevin M. Summers</h1> | ||
- | <img src="http://2012.igem.org/wiki/images/9/99/NevinSummers.jpg" style="max-width: | + | <img src="http://2012.igem.org/wiki/images/9/99/NevinSummers.jpg" style="max-width:250px;"/> |
is a visiting scientist at the Synthetic Biology Center at MIT and president of Novation, Inc., a consulting firm in Cambridge, MA providing due diligence, business planning, corporate development, and technology assessment services to venture capitalists, universities, and life science companies. Previously, he held executive positions at biotechnology companies. Trained as a molecular biologist and as an architect and urban designer, Nevin is exploring the application of synthetic biology to the diagnosis and treatment of disease, in particular the advancement of gene therapy from its early attempts with individual genes to contemporary multi-component "gene circuit therapy", capable of sensing changes in metabolic state, computing logical operations, and maintaining dynamic homeostasis. Nevin earned a BS in Molecular Biology at Johns Hopkins, an MArch at the Harvard Graduate School of Design and an SM in Management of Technology from MIT. He won First Prize in the Westinghouse-Intel Science Talent Search at the age of 17. | is a visiting scientist at the Synthetic Biology Center at MIT and president of Novation, Inc., a consulting firm in Cambridge, MA providing due diligence, business planning, corporate development, and technology assessment services to venture capitalists, universities, and life science companies. Previously, he held executive positions at biotechnology companies. Trained as a molecular biologist and as an architect and urban designer, Nevin is exploring the application of synthetic biology to the diagnosis and treatment of disease, in particular the advancement of gene therapy from its early attempts with individual genes to contemporary multi-component "gene circuit therapy", capable of sensing changes in metabolic state, computing logical operations, and maintaining dynamic homeostasis. Nevin earned a BS in Molecular Biology at Johns Hopkins, an MArch at the Harvard Graduate School of Design and an SM in Management of Technology from MIT. He won First Prize in the Westinghouse-Intel Science Talent Search at the age of 17. | ||
<div class="clear"></div> | <div class="clear"></div> | ||
Line 277: | Line 277: | ||
<div class="bio" id="tlbio"> | <div class="bio" id="tlbio"> | ||
<h1>Timothy Lu</h1> | <h1>Timothy Lu</h1> | ||
- | <img src="http://www.rle.mit.edu/rleonline/%5Cimages%5Cpeople%5CLu_Timothy.jpg" style="max-width: | + | <img src="http://www.rle.mit.edu/rleonline/%5Cimages%5Cpeople%5CLu_Timothy.jpg" style="max-width:250px;"/> |
has a PhD in Electrical and Biomedical Engineering from MIT in 2008. He is currently completing his MD degree in the Harvard/MIT HST program. In addition to other awards, Dr. Lu is the Lemelson-MIT student prize winner in 2008. In his PhD work with James Collins at BU/HHMI, Tim built and modeled artificial memory systems and counters in bacteria, and developed methods for delivering synthetically engineered bacteriophage to infection sites. His research focus is the development of synthetic-biology based solutions for pressing medical and industrial problems, using concepts from electronic circuits and systems design. His current focus is inventing effective treatments for infectious diseases and cancer using synthetic biology. | has a PhD in Electrical and Biomedical Engineering from MIT in 2008. He is currently completing his MD degree in the Harvard/MIT HST program. In addition to other awards, Dr. Lu is the Lemelson-MIT student prize winner in 2008. In his PhD work with James Collins at BU/HHMI, Tim built and modeled artificial memory systems and counters in bacteria, and developed methods for delivering synthetically engineered bacteriophage to infection sites. His research focus is the development of synthetic-biology based solutions for pressing medical and industrial problems, using concepts from electronic circuits and systems design. His current focus is inventing effective treatments for infectious diseases and cancer using synthetic biology. | ||
<div class="clear"></div> | <div class="clear"></div> | ||
Line 284: | Line 284: | ||
<div class="bio" id="tkbio"> | <div class="bio" id="tkbio"> | ||
<h1>Tom Knight</h1> | <h1>Tom Knight</h1> | ||
- | <img src="http://ginkgobioworks.com/images/bio-tk.jpg" style="max-width: | + | <img src="http://ginkgobioworks.com/images/bio-tk.jpg" style="max-width:250px;"/> |
is a senior research scientist in the MIT Computer Science and Artificial Intelligence Laboratory, part of the MIT School of Engineering. Inspired in part by the work of Harold Morowitz, a Yale physicist and biologist, Knight studied biochemistry, genetics, and cellular biology, and set up a biology lab within MIT's Laboratory for Computer Science. In this lab he created the concept of the BioBrick and began creating a library of BioBricks that could be used to build biological computation structures. Today, BioBricks form the basis of the iGEM (International Genetically Engineered Machine) competition. Knight continues to focus on Synthetic Biology at the Knight Laboratory. | is a senior research scientist in the MIT Computer Science and Artificial Intelligence Laboratory, part of the MIT School of Engineering. Inspired in part by the work of Harold Morowitz, a Yale physicist and biologist, Knight studied biochemistry, genetics, and cellular biology, and set up a biology lab within MIT's Laboratory for Computer Science. In this lab he created the concept of the BioBrick and began creating a library of BioBricks that could be used to build biological computation structures. Today, BioBricks form the basis of the iGEM (International Genetically Engineered Machine) competition. Knight continues to focus on Synthetic Biology at the Knight Laboratory. | ||
<div class="clear"></div> | <div class="clear"></div> | ||
Line 303: | Line 303: | ||
<div class="bio" id="rkbio"> | <div class="bio" id="rkbio"> | ||
<h1>Roger Kamm</h1> | <h1>Roger Kamm</h1> | ||
- | <img src="http://meche.mit.edu/people/img/rdkamm.jpg" style="max-width: | + | <img src="http://meche.mit.edu/people/img/rdkamm.jpg" style="max-width:250px; margin-right:10px"/> |
is the Germeshausen Professor of Mechanical and Biological Engineering and Associate Head of the Department of Mechanical Engineering at MIT. A primary objective of Kamm’s research group has been the application of fundamental concepts in fluid and solid mechanics to better understand essential biological and physiological phenomena. Studies over the past thirty years have addressed issues in the respiratory, ocular and cardiovascular systems. More recently, his attention has focused on two new areas, the molecular mechanisms of cellular force sensation, and the development of new scaffold materials and microfluidic technologies for vascularized engineered tissues. Kamm is a Fellow of the American Institute for Biomedical Engineering and the American Society for Mechanical Engineering. He is the current chair of the US National Committee on Biomechanics and the World Council on Biomechanics, and Director of the Global Enterprise for Micro Mechanics and Molecular Medicine. | is the Germeshausen Professor of Mechanical and Biological Engineering and Associate Head of the Department of Mechanical Engineering at MIT. A primary objective of Kamm’s research group has been the application of fundamental concepts in fluid and solid mechanics to better understand essential biological and physiological phenomena. Studies over the past thirty years have addressed issues in the respiratory, ocular and cardiovascular systems. More recently, his attention has focused on two new areas, the molecular mechanisms of cellular force sensation, and the development of new scaffold materials and microfluidic technologies for vascularized engineered tissues. Kamm is a Fellow of the American Institute for Biomedical Engineering and the American Society for Mechanical Engineering. He is the current chair of the US National Committee on Biomechanics and the World Council on Biomechanics, and Director of the Global Enterprise for Micro Mechanics and Molecular Medicine. | ||
<div class="clear"></div> | <div class="clear"></div> | ||
Line 310: | Line 310: | ||
<div class="bio" id="nakbio"> | <div class="bio" id="nakbio"> | ||
<h1>Natalie Kuldell</h1> | <h1>Natalie Kuldell</h1> | ||
- | <img src="http://web.mit.edu/be/images/kuldell.jpg" style="max-width: | + | <img src="http://web.mit.edu/be/images/kuldell.jpg" style="max-width:250px; margin-right:10px"/> |
did her doctoral and post-doctoral work at Harvard Medical School. She develops discovery-based curricula drawn from the current literature to engage undergraduate students in structured, reasonably authentic laboratory experiences. She has also written educational materials to improve scientific communication as it occurs across disciplinary boundaries and as it's taught in undergraduate subjects. Her research examines gene expression in eukaryotic cells, focusing most recently on synthetic biology and redesign of the yeast mitochondria. She serves as Associate Education Director for SynBERC, an NSF-funded research center for Synthetic Biology, and Councilor at Large for the Institute of Biological Engineering. | did her doctoral and post-doctoral work at Harvard Medical School. She develops discovery-based curricula drawn from the current literature to engage undergraduate students in structured, reasonably authentic laboratory experiences. She has also written educational materials to improve scientific communication as it occurs across disciplinary boundaries and as it's taught in undergraduate subjects. Her research examines gene expression in eukaryotic cells, focusing most recently on synthetic biology and redesign of the yeast mitochondria. She serves as Associate Education Director for SynBERC, an NSF-funded research center for Synthetic Biology, and Councilor at Large for the Institute of Biological Engineering. | ||
<div class="clear"></div> | <div class="clear"></div> | ||
Line 317: | Line 317: | ||
<div class="bio" id="mbbio"> | <div class="bio" id="mbbio"> | ||
<h1>Mark Bathe</h1> | <h1>Mark Bathe</h1> | ||
- | <img src="http://lcbb.mit.edu/people/portraits/bathe_mark.jpg" style="max-width: | + | <img src="http://lcbb.mit.edu/people/portraits/bathe_mark.jpg" style="max-width:250px; margin-right:10px;"/> |
joined MIT BE as an assistant professor in January 2009. Mark received his SB (1998), MS (2001), and Ph.D. (2004) in Mechanical Engineering from MIT, with his Ph.D. thesis supervised by Professor Bruce Tidor on computational analysis of proteoglycan and glycosaminoglycan structure and mechanics. During the period 2005-2008 he undertook postdoctoral work as an Alexander von Humboldt Research Fellow, first with Professor Erwin Frey at Ludwig Maximilian University in Munich Germany on theoretical modeling of cytoskeletal dynamics and then with Professor Marie France Carlier at CNRS in Paris France pursuing related cellular biophysics experiments. He has focused his efforts on multi-scale modeling from protein sequence to structure to spatio-temporal dynamics informed by microscopic imaging experimentation, as part of the highly collaborative Laboratory for Integrative Computational Cell Biology & Biophysics. | joined MIT BE as an assistant professor in January 2009. Mark received his SB (1998), MS (2001), and Ph.D. (2004) in Mechanical Engineering from MIT, with his Ph.D. thesis supervised by Professor Bruce Tidor on computational analysis of proteoglycan and glycosaminoglycan structure and mechanics. During the period 2005-2008 he undertook postdoctoral work as an Alexander von Humboldt Research Fellow, first with Professor Erwin Frey at Ludwig Maximilian University in Munich Germany on theoretical modeling of cytoskeletal dynamics and then with Professor Marie France Carlier at CNRS in Paris France pursuing related cellular biophysics experiments. He has focused his efforts on multi-scale modeling from protein sequence to structure to spatio-temporal dynamics informed by microscopic imaging experimentation, as part of the highly collaborative Laboratory for Integrative Computational Cell Biology & Biophysics. | ||
<div class="clear"></div> | <div class="clear"></div> | ||
Line 324: | Line 324: | ||
<div class="bio" id="chvbio"> | <div class="bio" id="chvbio"> | ||
<h1>Christopher Voigt</h1> | <h1>Christopher Voigt</h1> | ||
- | <img src="http://web.mit.edu/be/images/voigt.jpg" style="max-width: | + | <img src="http://web.mit.edu/be/images/voigt.jpg" style="max-width:250px; margin-right:10px;"/> |
joined the Department of Biological Engineering as a tenured Associate Professor in July 2011 at MIT. Among his awards are Packard Fellow, Sloan Fellow, Pew Scholar, NSF CAREER, and recognition for “Top 10 Technologies of 2009” from The Scientist. He is a founding Co-Director of MIT’s Synthetic Biology Center. | joined the Department of Biological Engineering as a tenured Associate Professor in July 2011 at MIT. Among his awards are Packard Fellow, Sloan Fellow, Pew Scholar, NSF CAREER, and recognition for “Top 10 Technologies of 2009” from The Scientist. He is a founding Co-Director of MIT’s Synthetic Biology Center. | ||
<div class="clear"></div> | <div class="clear"></div> | ||
Line 331: | Line 331: | ||
<div class="bio" id="pacbio"> | <div class="bio" id="pacbio"> | ||
<h1>Peter Andrew Carr</h1> | <h1>Peter Andrew Carr</h1> | ||
- | <img src="http://web.mit.edu/lms/www/images/people/Peter%20Carr,%20USA%20%28Custom%29.JPG" style="max-width: | + | <img src="http://web.mit.edu/lms/www/images/people/Peter%20Carr,%20USA%20%28Custom%29.JPG" style="max-width:250px; margin-right:10px;"/> |
focuses on increasing the scale at which we can engineer organisms, up to entire genomes. Current projects in my lab include: 1) high throughput microfluidic gene and protein synthesis for rapid prototyping of engineered genetic systems; 2) re-engineering the genetic code of microbesproviding plug-and-play capabilities for non-natural amino acids, and constructing "genetic firewalls" to block gene flow to and from of these organisms; 3) error correction methods for de novo synthesized DNA; 4) Control systems and safety standards for engineered organisms. I received my bachelors degree in biochemistry from Harvard College and my Ph.D. in biochemistry and molecular biophysics from Columbia University. | focuses on increasing the scale at which we can engineer organisms, up to entire genomes. Current projects in my lab include: 1) high throughput microfluidic gene and protein synthesis for rapid prototyping of engineered genetic systems; 2) re-engineering the genetic code of microbesproviding plug-and-play capabilities for non-natural amino acids, and constructing "genetic firewalls" to block gene flow to and from of these organisms; 3) error correction methods for de novo synthesized DNA; 4) Control systems and safety standards for engineered organisms. I received my bachelors degree in biochemistry from Harvard College and my Ph.D. in biochemistry and molecular biophysics from Columbia University. | ||
<p><a href="http://web.mit.edu/lms/www/peoplepages/Peter_Carr.htm">Lab Website</a></p> | <p><a href="http://web.mit.edu/lms/www/peoplepages/Peter_Carr.htm">Lab Website</a></p> | ||
Line 339: | Line 339: | ||
<div class="bio" id="rsbio"> | <div class="bio" id="rsbio"> | ||
<h1>Rahul Sarpeshkar</h1> | <h1>Rahul Sarpeshkar</h1> | ||
- | <img src="http://2011.igem.org/wiki/images/5/59/RahulSarpeshkar.jpg" style="max-width: | + | <img src="http://2011.igem.org/wiki/images/5/59/RahulSarpeshkar.jpg" style="max-width:250px; margin-right:10px;"/> |
obtained his Bachelor's degrees in Electrical Engineering and Physics at MIT. After completing his PhD at Caltech, he joined Bell Labs as a member of technical staff in the department of Biological Computation within its Physics division. Since 1999, he has been on the faculty of MIT's Electrical Engineering and Computer Science Department where he heads a research group on <a href="http://www.rle.mit.edu/acbs/">Analog Circuits and Biological Systems </a>. His invention of cytomorphic electronics, outlined in his recent book, Ultra Low Power Bioelectronics: Fundamentals, Biomedical Applications, and Bio-inspired Systems, has established an important bridge between electronics and chemistry. This work lays a foundation for a rigorous analog circuits approach to systems biology and synthetic biology. His current research on synthetic biology applies analog circuit techniques to the design, analysis, implementation, and supercomputing chip-based simulation of biochemical networks in E coli and yeast. It has applications in architecting a scalable platform technology and conceptual framework for design that is broadly applicable in all of synthetic biology. It also has specific applications in the treatment of diabetes, antibiotic resistance, and the design of microbial fuel cells. He has received several awards including the NSF Career Award, the ONR Young Investigator Award, the Packard Fellows Award and the Indus Technovator Award for his interdisciplinary bioengineering research. | obtained his Bachelor's degrees in Electrical Engineering and Physics at MIT. After completing his PhD at Caltech, he joined Bell Labs as a member of technical staff in the department of Biological Computation within its Physics division. Since 1999, he has been on the faculty of MIT's Electrical Engineering and Computer Science Department where he heads a research group on <a href="http://www.rle.mit.edu/acbs/">Analog Circuits and Biological Systems </a>. His invention of cytomorphic electronics, outlined in his recent book, Ultra Low Power Bioelectronics: Fundamentals, Biomedical Applications, and Bio-inspired Systems, has established an important bridge between electronics and chemistry. This work lays a foundation for a rigorous analog circuits approach to systems biology and synthetic biology. His current research on synthetic biology applies analog circuit techniques to the design, analysis, implementation, and supercomputing chip-based simulation of biochemical networks in E coli and yeast. It has applications in architecting a scalable platform technology and conceptual framework for design that is broadly applicable in all of synthetic biology. It also has specific applications in the treatment of diabetes, antibiotic resistance, and the design of microbial fuel cells. He has received several awards including the NSF Career Award, the ONR Young Investigator Award, the Packard Fellows Award and the Indus Technovator Award for his interdisciplinary bioengineering research. | ||
<div class="clear"></div> | <div class="clear"></div> | ||
Line 346: | Line 346: | ||
<div class="bio" id="nmbio"> | <div class="bio" id="nmbio"> | ||
<h1>Narendra Maheshri</h1> | <h1>Narendra Maheshri</h1> | ||
- | <img src="http://web.mit.edu/~narendra/www/people_images/NARENDRAsq.jpg" style="max-width: | + | <img src="http://web.mit.edu/~narendra/www/people_images/NARENDRAsq.jpg" style="max-width:250px; margin-right:10px;"/> |
is an Assistant Professor of Chemical Engineering at the Massachusetts Institute of Technology (MIT). He has bachelor’s degrees in both Chemical Engineering and Biology from MIT, and a PhD in Chemical Engineering from the University of California (UC) Berkeley, where he focused on engineering viral vectors for gene therapy. In his post-doctoral studies at UC San Francisco and Harvard, he became interested in systems’ biology and gene regulation. His current research interests are in understanding the dynamics of gene regulation and gene regulatory networks in single cells using a combined experimental and theoretical approach. | is an Assistant Professor of Chemical Engineering at the Massachusetts Institute of Technology (MIT). He has bachelor’s degrees in both Chemical Engineering and Biology from MIT, and a PhD in Chemical Engineering from the University of California (UC) Berkeley, where he focused on engineering viral vectors for gene therapy. In his post-doctoral studies at UC San Francisco and Harvard, he became interested in systems’ biology and gene regulation. His current research interests are in understanding the dynamics of gene regulation and gene regulatory networks in single cells using a combined experimental and theoretical approach. | ||
<div class="clear"></div> | <div class="clear"></div> | ||
Line 353: | Line 353: | ||
<div class="bio" id="fzbio"> | <div class="bio" id="fzbio"> | ||
<h1>Feng Zhang</h1> | <h1>Feng Zhang</h1> | ||
- | <img src="http://mcgovern.mit.edu/images/stories/PIs/zhang_large.png" style="max-width: | + | <img src="http://mcgovern.mit.edu/images/stories/PIs/zhang_large.png" style="max-width:250px; margin-right:10px;"/> |
is an assistant professor is MIT's department of Brain and Cognitive Sciences. | is an assistant professor is MIT's department of Brain and Cognitive Sciences. | ||
Line 362: | Line 362: | ||
<div class="bio" id="dvbio"> | <div class="bio" id="dvbio"> | ||
<h1>Domitilla Del Vecchio</h1> | <h1>Domitilla Del Vecchio</h1> | ||
- | <img src="http://www.mit.edu/~ddv/ddv2.JPG" style="max-width: | + | <img src="http://www.mit.edu/~ddv/ddv2.JPG" style="max-width:250px; margin-right:10px;"/> |
is a Keck Career Development Assistant Professor at MIT's department of Mechanical Engineering. | is a Keck Career Development Assistant Professor at MIT's department of Mechanical Engineering. | ||
Line 372: | Line 372: | ||
<div class="bio" id="jnbio"> | <div class="bio" id="jnbio"> | ||
<h1>Jacquin Niles</h1> | <h1>Jacquin Niles</h1> | ||
- | <img src="http://web.mit.edu/be/images/niles.jpg" style="max-width: | + | <img src="http://web.mit.edu/be/images/niles.jpg" style="max-width:250px; margin-right:10px;"/> |
is a Pfizer-Laubach Career Development Assistant Professor of Biological Engineering at MIT's department of Biological Engineering. | is a Pfizer-Laubach Career Development Assistant Professor of Biological Engineering at MIT's department of Biological Engineering. | ||
Line 384: | Line 384: | ||
<div class="bio" id="kpbio"> | <div class="bio" id="kpbio"> | ||
<h1>Kristala L. Jones Prather</h1> | <h1>Kristala L. Jones Prather</h1> | ||
- | <img src="http://web.mit.edu/prathergroup/images/KrisChemE.png" style="max-width: | + | <img src="http://web.mit.edu/prathergroup/images/KrisChemE.png" style="max-width:250px; margin-right:10px"/> |
is an associate professor at MIT's department of Chemical Engineering. | is an associate professor at MIT's department of Chemical Engineering. | ||
<p><a href="http://web.mit.edu/prathergroup/">Biography</a></p> | <p><a href="http://web.mit.edu/prathergroup/">Biography</a></p> | ||
Line 409: | Line 409: | ||
<div class="bio" id="sjbio"> | <div class="bio" id="sjbio"> | ||
<h1>Shridhar Jayanthi</h1> | <h1>Shridhar Jayanthi</h1> | ||
- | <img src="http://web.mit.edu/ddv/www/pictures/sjayanthi.jpg" style="max-width: | + | <img src="http://web.mit.edu/ddv/www/pictures/sjayanthi.jpg" style="max-width:250px; margin-right:10px"/> |
is a graduate student under Domitilla Del Vecchio. | is a graduate student under Domitilla Del Vecchio. | ||
Line 427: | Line 427: | ||
<div class="bio" id="sfbio"> | <div class="bio" id="sfbio"> | ||
<h1>Shawn Finney-Manchester</h1> | <h1>Shawn Finney-Manchester</h1> | ||
- | <img src="http://web.mit.edu/~narendra/www/leah_images/ShawnSq.jpg" style="max-width: | + | <img src="http://web.mit.edu/~narendra/www/leah_images/ShawnSq.jpg" style="max-width:250px; margin-right:10px"/> |
is a graduate student under Narendra Maheshri. | is a graduate student under Narendra Maheshri. | ||
Revision as of 14:16, 30 September 2012
Jenna Klein

Katie Bodner

Nathan Kipniss

Felix Sun

Ala’a Siam

Kristjan Eerik Kaseniit

Robert Learsch

Lihn Vuong

Chelsea Voss

Wilson Louie

Jonathan Elzur

Eta Atolia

Keren Greenbaum

Giulio Alighieri

Divya Israni

Lealia Xiong

Ron Weiss

Jonathan Babb

Deepak Mishra

Peter Andrew Carr
Lulu Qian

Nevin M. Summers

Timothy Lu

Tom Knight

Linda Griffith
heads the Griffith Lab at MIT. She was an Area Head for the Bioengineering and Mechanical Engineering Department. She is also the director of the MIT Biotechnology Process Engineering Center as well as a professor of Mechanical and Biological Engineering at MIT.Alice M. Rushforth
is the Program Manager for MIT for the Center for Emergent Behaviors of Integrated Cellular Systems (EBICS).Roger Kamm

Natalie Kuldell

Mark Bathe

Christopher Voigt

Peter Andrew Carr
Rahul Sarpeshkar

Narendra Maheshri

Domitilla Del Vecchio
Jacquin Niles

Kristala L. Jones Prather

Our Team
Meet the 2012 MIT iGEM Team!
